Ciprofloxacin prophylaxis during autologous stem cell transplantation for multiple myeloma in patients with a high rate of fluoroquinolone-resistant gram-negative bacteria colonization
Jazyk angličtina Země Česko Médium print-electronic
Typ dokumentu časopisecké články
PubMed
30198521
DOI
10.5507/bp.2018.047
Knihovny.cz E-zdroje
- Klíčová slova
- autologous transplantation, ciprofloxacin prophylaxis, multiple myeloma, neutropenia,
- MeSH
- antibakteriální látky terapeutické užití MeSH
- antibiotická profylaxe * MeSH
- autologní transplantace MeSH
- bakteriální infekce prevence a kontrola MeSH
- bakteriální léková rezistence MeSH
- ciprofloxacin terapeutické užití MeSH
- dospělí MeSH
- gramnegativní bakteriální infekce epidemiologie MeSH
- gramnegativní bakterie fyziologie MeSH
- infekce vyvolané Escherichia coli epidemiologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- mnohočetný myelom terapie MeSH
- přenašečství epidemiologie MeSH
- pseudomembranózní enterokolitida epidemiologie MeSH
- retrospektivní studie MeSH
- senioři MeSH
- stafylokokové infekce epidemiologie MeSH
- transplantace kmenových buněk metody MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- antibakteriální látky MeSH
- ciprofloxacin MeSH
BACKGROUND: Ciprofloxacin prophylaxis used to be a standard precaution during autologous stem cell transplantation. Its benefit, with a high prevalence of fluoroqinolone resistance in the population, has recently been under scrutiny. OBJECTIVE: To evaluate the impact of cessation of ciprofloxacin prophylaxis during stem cell transplantation for multiple myeloma. PATIENTS AND METHODS: Data from 104 patients with multiple myeloma transplanted during the period from January 2013 to April 2015 were retrospectively reviewed. 67 received standard ciprofloxacin prophylaxis (group A) and 37 received no antibacterial prophylaxis (group B). RESULTS: Febrile episodes during neutropenia, bloodstream infection (BSI) and mortality in these two cohorts were evaluated. Gram negative BSI was assessed for the colonization of quinolone-resistant gram-negative pathogens. Secondary Clostridium difficile enterocolitis presence was determined in both cohorts. There were 42 (63%), 7 (10%), and 0 febrile episodes, BSI and gram-negative BSI respectively in group A, and 34 (92%), 12 (32%), and 4 (11%) respectively in group B. The differences in the number of febrile episodes (P=0.0011) and deaths (P=0.0427) were statistically significance. Mortality was 0 and 3 (8%) in group A and group B, respectively. There was no significant difference in colonization with quinolone-resistant gram negative pathogens (25 (37%) versus 11 (30%)) between groups. The occurrence of Clostridium difficile colitis was the same in both groups. CONCLUSION: We resumed ciprofloxacin prophylaxis for the following reasons. There was a significant reduction in febrile episodes, and consequently a sparing effect of antibiotics used for treatment of this condition. No difference in Clostridium difficile colitis occurred and the mortality rate of 8% in group B was unacceptably high.
Citace poskytuje Crossref.org